Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenson A Jassim

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|May 31, 2022
PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapyBrenson A Jassim, Jianping Lin, Zhong-Yin Zhang
European Journal of Medicinal Chemistry|December 18, 2024
Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacyBrenson A Jassim, Yunpeng Bai, Zihan Qu, et al.
Medchemcomm|June 27, 2017
Discovery of Decamidine as a New and Potent PRMT1 InhibitorJing Zhang, Kun Qian, Chunli Yan, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor ActivityJinmin Miao, Yunpeng Bai, Yiming Miao, et al.
Journal of Medicinal Chemistry|July 2, 2026
A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic ActivityJianping Lin, Brenson A Jassim, Yunpeng Bai, et al.
Journal of Medicinal Chemistry|May 20, 2024
Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 PhosphatasesJiajun Dong, Brenson A Jassim, Kedric L Milholland, et al.
Chemical Science|November 29, 2023
Discovery of a selective TC-PTP degrader for cancer immunotherapyJinmin Miao, Jiajun Dong, Yiming Miao, et al.
Angewandte Chemie (International Ed. in English)|March 27, 2023
Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer ImmunotherapyJiajun Dong, Jinmin Miao, Yiming Miao, et al.
Journal of Medicinal Chemistry|April 16, 2025
Discovery and Evaluation of Active Site-Directed, Potent, and Selective Sulfophenyl Acetic Amide-Based Inhibitors for the Laforin PhosphataseJianping Lin, Rongjun He, Zihan Qu, et al.
Angewandte Chemie (International Ed. in English)|December 27, 2025
Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic ActivityZihan Qu, Frederick Nguele Meke, Zheng Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|May 31, 2022
PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapyBrenson A Jassim, Jianping Lin, Zhong-Yin Zhang
European Journal of Medicinal Chemistry|December 18, 2024
Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacyBrenson A Jassim, Yunpeng Bai, Zihan Qu, et al.
Medchemcomm|June 27, 2017
Discovery of Decamidine as a New and Potent PRMT1 InhibitorJing Zhang, Kun Qian, Chunli Yan, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor ActivityJinmin Miao, Yunpeng Bai, Yiming Miao, et al.
Journal of Medicinal Chemistry|July 2, 2026
A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic ActivityJianping Lin, Brenson A Jassim, Yunpeng Bai, et al.
Journal of Medicinal Chemistry|May 20, 2024
Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 PhosphatasesJiajun Dong, Brenson A Jassim, Kedric L Milholland, et al.
Chemical Science|November 29, 2023
Discovery of a selective TC-PTP degrader for cancer immunotherapyJinmin Miao, Jiajun Dong, Yiming Miao, et al.
Angewandte Chemie (International Ed. in English)|March 27, 2023
Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer ImmunotherapyJiajun Dong, Jinmin Miao, Yiming Miao, et al.
Journal of Medicinal Chemistry|April 16, 2025
Discovery and Evaluation of Active Site-Directed, Potent, and Selective Sulfophenyl Acetic Amide-Based Inhibitors for the Laforin PhosphataseJianping Lin, Rongjun He, Zihan Qu, et al.
Angewandte Chemie (International Ed. in English)|December 27, 2025
Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic ActivityZihan Qu, Frederick Nguele Meke, Zheng Zhang, et al.
Pageof 1